Bioavailability Based on the Gut Microbiota: a New Perspective

Abstract

SUMMARY The substantial discrepancy between the strong effects of functional foods and various drugs, especially traditional Chinese medicines (TCMs), and the poor bioavailability of these substances remains a perplexing problem. Understanding the gut microbiota, which acts as an effective bioreactor in the human intestinal tract, provides an opportunity for the redefinition of bioavailability. Here, we discuss four different pathways associated with the role of the gut microbiota in the transformation of parent compounds to beneficial or detrimental small molecules, which can enter the body’s circulatory system and be available to target cells, tissues, and organs. We further describe and propose effective strategies for improving bioavailability and alleviating side effects with the help of the gut microbiota. This review also broadens our perspectives for the discovery of new medicinal components.

Alterations in the Gut Microbiota and Hepatitis-B-Virus Infection in Southern Chinese Patients With Coexisting Non-Alcoholic Fatty Liver Disease and Type-2 Diabetes Mellitus

“…Gemmiger species were negatively related to glucose metabolism, including the TCA cycle and galactose metabolism. Short-chain fatty acids (SCFAs) reduce lipid accumulation and insulin resistance (35). SCFAs-producing microbiotas are involved in gluconeogenesis, reduce the TG level, and promote energy storage (36).…”

Positive Interventional Effect of Engineered Butyrate-Producing Bacteria on Metabolic Disorders and Intestinal Flora Disruption in Obese Mice

“…Moreover, butyrate has a good effect on preventing and suppressing obesity by improving the glucose homeostasis, insulin sensitivity, and function of the intestinal microbiota ( 13 , 14 , 19 , 21 ). Butyrate supplementation seems to be an effective obesity treatment strategy, but it often has low bioavailability, and direct butyrate supplementation has a poor sustained effect ( 21 , 22 ). Bacillus subtilis is a food-grade probiotic with a clear genetic background and a good load expression system ( 23 ).…”

Pharmacokinetic, Metabolism, and Metabolomic Strategies Provide Deep Insight Into the Underlying Mechanism of Ginkgo biloba Flavonoids in the Treatment of Cardiovascular Disease

“…The metabolism of gut microbiota may also affect the bioavailability of the flavonoids ( 78 ). Hanske et al ( 79 ) investigated the effect of human gut microbiota on bioavailability of apigenin-7-glucoside (A7G) in vitro and in germ-free and human gut microbiota-associated (HMA) rats.…”